Opinion|Videos|April 4, 2024
Allocation of Investment and Value-Based Arrangements in Diabetes Care
Insights on how payers can allocate their resources to best improve outcomes for patients with diabetes.
Advertisement
Episodes in this series
Advertisement
Related to this article
Onswik is approved to improve glycemic control in adults with Type 2 diabetes and will be available in the United States in the coming months in two concentrations. No information is available on the list price.
UCLA research suggests that GLP-1 therapies may protect bone health in Type 2 diabetes patients.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
When the referral isn't the finish line: Making SDOH programs actually close care gaps
2
A conversation with Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, about the relationship between HIV incidence in Hispanic communities and immigration policy
3
CMS defined a path for medical frailty. Now comes the hard part.
4
Closing the outpatient monitoring gap in cancer
5